Screener by Innerkore

Fermenta Biotech Limited

NSE: FERMENTABSE: 506414HealthcarePharmaceuticals & Biotechnology

Fermenta Biotech Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: FERMENTA and BSE: 506414 (ISIN INE225B01021).

It has a market capitalisation of ₹1,320 crore, a last close of ₹460.50 on 2026-10-19.

Valuation: a price-to-book ratio of 3.25x, a dividend yield of 0.8%.

Profitability: return on equity of 0.0%, return on capital employed of 25.5%, an operating margin of 19.0%.

Growth: sales growth of 14.5% a year over three years.

Balance sheet and ownership: debt-to-equity of 0.27x, promoter holding of 60.1%.

Key figures for FERMENTA, prices as of 2026-10-19
MetricValue
Market capitalisation1,320
Last close₹460.50
P/B3.25x
Dividend yield0.8%
ROE (FY)0.0%
ROCE (FY)25.5%
Operating margin (TTM)19.0%
Sales growth, 3-year CAGR14.5%
Debt / equity0.27x
Promoter holding60.1%

Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means